Amgen – Amgen Inc. stock underperforms Monday when compared to competitors
Shares of Amgen Inc.
sank 0.65% to $241.19 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index
rising 0.18% to 4,255.15 and the Dow Jones Industrial Average
falling 0.25% to 34,393.75. This was the stock’s second consecutive day of losses. Amgen Inc. closed $35.50 short of its 52-week high ($276.69), which the company reached on January 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson
rose 0.25% to $165.37, Roche Holding AG Part. Cert.
rose 2.24% to $388.50, and Pfizer Inc.
fell 1.30% to $39.63. Trading volume (2.1 M) remained 528,615 below its 50-day average volume of 2.6 M.